Steris (STE) Receivables - Other (2019 - 2020)
Steris (STE) posted Receivables - Other of $9.0 million for Q4 2020, up 4.93% on a QoQ basis from $8.5 million in Q3 2020.
Analysis
Steris (STE) Receivables - Other (2019 - 2020) Analysis & Trends
Steris has reported Receivables - Other for 2 years, with the latest figure at $9.0 million in Q4 2020.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to $9.0 million in Q4 2020; TTM through Dec 2020 was $9.0 million, a N/A change from a year earlier, with the FY2020 full-year figure at $8.1 million, down 4.97% from the prior year.
- Receivables - Other was $9.0 million for Q4 2020 at Steris, up from $8.5 million in the prior quarter.
- The five-year high for Receivables - Other was $9.0 million in Q4 2020, with the low at $8.1 million in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.57 Bn | 174.97 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.53 Bn | 122.31 Bn | 1.96 Bn |
| 3 | Medtronic | 116.86 Bn | 108.04 Bn | 6.34 Bn |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.57 Bn | 63.03 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.82 Bn | 45.57 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.16 Bn | 30.21 Bn | 830.00 Mn |
| 9 | Steris | 20.64 Bn | 20.16 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 17.62 Bn | 17.21 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 8.97 Mn |
| Sep 30, 2020 | 8.55 Mn |
| Mar 31, 2020 | 8.07 Mn |
| Mar 31, 2019 | 8.49 Mn |